NCT02349282已完成不适用
The Effect of Calcifediol (Hy.D 25 SD/S) and Vitamin D3 on Muscle Strength in a Frail Elderly Population: a Randomized, Double-blind, Placebo-controlled Trial.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 78
- 试验地点
- 2
- 主要终点
- Change in muscle strength, knee extension strength (measured by Biodex System)
研究概览
简要总结
In an ageing population, the need for interventions to help older people remain healthy, active and independent for as long as possible, increases. Although several studies suggest a beneficial effect of vitamin D3 on maintaining or improving muscle strength and physical functioning, particularly in vulnerable populations, results are contradicting. Randomized, placebo-controlled trials are needed to further establish the effect of vitamin D on muscle strength in the frail elderly population.The primary aim of this study is to determine the effect of daily supplementation with two different forms of vitamin D on muscle strength in frail elderly people over a period of 24 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •25(OH)D levels 20-50 nmol/L.
- •age 65 or older.
- •physically frail (pre-frail or frail, based on the criteria designed by Fried et al.) (30). Frailty will be defined as a clinical syndrome in which one or more of the following criteria are present: unintentional weight loss (4.5 kg in past year), self-reported exhaustion (CES-D questionnaire), weakness (grip strength), slow walking speed and low physical activity (Minnesota questionnaire). More details on these criteria are described in chapter 6.3.
- •body mass index between 18.5 and 35 kg/m
- •willingness and ability to comply with the protocol, including performance of the knee extension strength test.
排除标准
- •Medical Illness:
- •malabsorption syndrome: known intestinal malabsorption, celiac diseases, inflammatory bowel disease;
- •diseases that may enhance serum calcium concentration: sarcoidosis, lymphoma, kidney stone in the last 10 years, primary hyperparathyroidism;
- •abnormal indices of calcium metabolism, uncontrolled hypocalcaemia;
- •diagnosed renal insufficiency;
- •diagnosed cancer; currently diagnosed or undergoing treatment.
- •Hypercalcemia: serum calcium adjusted for albumin of > 2.6 nmol/L.
- •Medication: interfering with vitamin D metabolism and vitamin D supplementation (bisphosphonate, PTH treatment, tuberculostatica, anti-epileptica).
- •Subject not able (when medically necessary/ advised) or not willing to stop the use of vitamin D containing supplements during the study.
- •(Expected) increase in exposure to sunlight (e.g. travelling to a sunny resort) during intervention period.
- •Patient heavily consumes alcohol containing products defined as greater than > 21 drinks of alcoholic beverages per week.
- •Planned surgery which can affect study measures (taking into account duration of hospitalisation and recovery).
- •Participation in another clinical trial.
结局指标
主要结局
Change in muscle strength, knee extension strength (measured by Biodex System)
时间窗: baseline, week 12, end of study (after 24 weeks supplementation)
measured by Biodex System
次要结局
- Change in serum 25(OH)D(baseline, week 12, end of study (after 24 weeks supplementation))
- Change in serum 24,25(OH)2D(baseline, week 12, end of study (after 24 weeks supplementation))
- Change in vital Signs (blood pressure and heart rate)(baseline, week 12, end of study (after 24 weeks supplementation))
- Change in Timed Up and Go test(baseline, week 12, end of study (after 24 weeks supplementation))
- Change in Postural Body Sway(baseline, week 12, end of study (after 24 weeks supplementation))
- Change in serum 1,25(OH)2D3(baseline, week 12, end of study (after 24 weeks supplementation))
- Change in knee flexion strength (measured by Biodex System)(baseline, week 12, end of study (after 24 weeks supplementation))
- Change in SPPB(baseline, week 12, end of study (after 24 weeks supplementation))
- Change in serum Vitamin D3(baseline, week 12, end of study (after 24 weeks supplementation))
- Change in handgrip strength(baseline, week 12, end of study (after 24 weeks supplementation))
- Frequency of falling(baseline, week 12, end of study (after 24 weeks supplementation))
- Change in muscle fibre type and size (Biopsy)(baseline, end of study (after 24 weeks supplementation))
- Change in body composition (DEXA-scan)(baseline, end of study (after 24 weeks supplementation))
- Change in cognitive functioning (Trail making, Stroop-test, Letter fluency)(baseline, end of study (after 24 weeks supplementation))
- Change in neuromuscular measurements (MUNIX, MUSIX by EMG)(baseline, end of study (after 24 weeks supplementation))
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Dose Finding Study in Physically Frail Elderly to Measure 25(OH) Vitamin D Levels After Supplementation With Hy.D Calcifediol 25 SD/S and Vitamin D3Pre-frail ElderlyFrail ElderlyNCT01868945DSM Nutritional Products, Inc.59
Unknown
3 期
Prevention of Falls and Fractures in Old People by Administration of Calcium and Vitamin D. Randomized Clinical TrialFallFracturesNCT01452243Gerencia de Atención Primaria, Albacete704
已完成
3 期
The Effect of Cholecalciferol in Pre-frail ElderlyPre-frail ElderlyNCT04847947Indonesia University120
已完成
不适用
Nutrient Support to Body Composition and Healthy AgeingSarcopeniaOsteopeniaNCT02529124Phil Jakeman254
已完成
2 期
Activated Vitamin D for the Prevention and Treatment of Acute Kidney InjuryCritically IllAcute Kidney InjuryNCT02962102David Leaf150